ID: ALA2336369

Max Phase: Preclinical

Molecular Formula: C7H9N7

Molecular Weight: 191.20

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cn1cnc2c(NC(=N)N)ncnc21

Standard InChI:  InChI=1S/C7H9N7/c1-14-3-12-4-5(13-7(8)9)10-2-11-6(4)14/h2-3H,1H3,(H4,8,9,10,11,13)

Standard InChI Key:  NECSZQJTCBFYIK-UHFFFAOYSA-N

Associated Targets(Human)

Aurora kinase A/B 33 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MCF7 126967 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cyclin-dependent kinase 2/cyclin E1 1877 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cyclin-dependent kinase 1/cyclin B1 1887 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 191.20Molecular Weight (Monoisotopic): 191.0919AlogP: -0.33#Rotatable Bonds: 1
Polar Surface Area: 105.50Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.23CX LogP: -0.50CX LogD: -1.39
Aromatic Rings: 2Heavy Atoms: 14QED Weighted: 0.42Np Likeness Score: -0.58

References

1. Dolečková I, Cesnek M, Dračinský M, Brynda J, Voller J, Janeba Z, Kryštof V..  (2013)  Synthesis and biological evaluation of guanidino analogues of roscovitine.,  62  [PMID:23399722] [10.1016/j.ejmech.2013.01.021]

Source